Erlotinib induced ectropion following papulopustular rash

Creative Commons License

Salman A., ÇERMAN E., Seckin D., Kanitez M.

JOURNAL OF DERMATOLOGICAL CASE REPORTS, cilt.9, sa.2, ss.45-47, 2015 (ESCI) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 9 Sayı: 2
  • Basım Tarihi: 2015
  • Doi Numarası: 10.3315/jdcr.2015.1203
  • Dergi Adı: JOURNAL OF DERMATOLOGICAL CASE REPORTS
  • Derginin Tarandığı İndeksler: Emerging Sources Citation Index (ESCI), Scopus
  • Sayfa Sayıları: ss.45-47
  • Anahtar Kelimeler: adverse effects, ectropion, eye, erlotinib, papulopustular rash, FACTOR RECEPTOR INHIBITORS, CICATRICIAL ECTROPION, TOXICITIES
  • Acıbadem Mehmet Ali Aydınlar Üniversitesi Adresli: Hayır

Özet

Background: Erlotinib is a targeted anti-cancer drug which acts through the inhibition of epidermal growth factor receptor (EGFR).